JoelAaronBrochsteinMD

Pediatric Hematology & Oncology • New Hyde Park, NY

Associate Professor, Pediatrics, Hofstra North Shore-LIJ

Join to view full profile

Dr. Brochstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brochstein's full profile

Already have an account?

Office
269-01 76th Avenue
Suite 255
New Hyde Park, NY 11040
Phone+1 718-470-3460

Fax+1 718-343-4642

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1980 - 1983
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1979 - 1980
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1977 - 1979
Weill Cornell MedicineClass of 1977

Certifications & Licensure

NY State Medical License 1978 - 2025
NJ State Medical License 1981 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia Start of enrollment: 1999 Jan 01
Completed
Phase 2
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
Completed
Phase 3
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Start of enrollment: 2005 Sep 01
Completed
Phase 2
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
Completed
Phase 1, Phase 2
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

1 citations
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein
American Journal of Hematology. 2024-04-01
19 citations
Allogeneic stem cell transplantation with omidubicel in sickle cell disease.
Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurelie Schwarzbach, Joanne Kurtzberg
Blood Advances. 2021-02-09
4 citations
Timing of Alemtuzumab With Respect to Day of Bone Marrow Infusion and its Effects Upon Engraftment and Graft-Versus-Host Disease in Patients With Sickle Cell Disease: ...
Indira Sahdev, Joel A. Brochstein, Nan Werther, Jessica Stiles
Journal of Pediatric Hematology/oncology. 2020-11-01

Professional Memberships

American Academy of Pediatrics - AAP
Fellow